Back

Targeting RNA for treatment of dyslipidaemias.

26 August 2022 (17:00 - 17:15)
Organised by:
Congress Presentation Part of: Emerging role of RNAs as treatment targets in cardiovascular disease Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Sotirios Tsimikas

University of California San Diego, La Jolla (United States of America)

3 More presentations in this session

Presentation thumbnail
Targeting RNA to reverse pathological cardiac hypertrophy.
Professor T. Thum (Hannover, DE)
Slides Video
Presentation thumbnail
Targeting RNA to facilitate cardiac remodelling and to treat heart failure.
Mrs P. da Costa Martins (Maastricht, NL)
Slides Video
Presentation thumbnail
Emerging role of RNAs as treatment targets in cardiovascular disease – discussion.

Access the full session

Session thumbnail
Emerging role of RNAs as treatment targets in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 17:00 CET
You may be interested in
thumbnail
Congress Presentation
RNA-based therapy in dyslipidaemia
27 August 2023
thumbnail
Congress Presentation
PCSK9 inhibition: new insights
1 September 2024
thumbnail
Congress Presentation
Strategies to deliver therapeutic RNAs in cardiovascular diseases
2 September 2024
thumbnail
Congress Presentation
The future of lipid management: novel therapeutics and the path forward
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources